Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

about

Coatings as the useful drug delivery system for the prevention of implant-related infections

P2860

Q58768791-07B19D50-18F4-428D-82A6-050086F196C0

P2860

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

Item

http://www.wikidata.org/entity/Q41656732

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

@en

type

Item

label

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

@en

prefLabel

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

@en

P1476

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

@en

P2093

Berna Kankilic

http://www.w3.org/2001/XMLSchema#string

Elif Bilgic

http://www.w3.org/2001/XMLSchema#string

Feza Korkusuz

http://www.w3.org/2001/XMLSchema#string

Petek Korkusuz

http://www.w3.org/2001/XMLSchema#string

P2860

Osteomyelitis.

A different perspective for radiological evaluation of experimental osteomyelitis.

Organic-inorganic composites for bone drug delivery.

Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives.

Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis.

Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized β-tricalcium phosphate scaffold.

Infection and musculoskeletal conditions: Prosthetic-joint-associated infections.

An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.

Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity

Vancomycin containing PLLA/β-TCP controls MRSA in vitro.

P2888

s13018-014-0114-3

P304

114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13018-014-0114-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268795367

http://www.w3.org/2001/XMLSchema#string

P6179

1014283637

http://www.w3.org/2001/XMLSchema#string

P698

25407446

http://www.w3.org/2001/XMLSchema#string

P932

4243329

http://www.w3.org/2001/XMLSchema#string

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

about

P2860

P2860

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932